Short description
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Description
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic that has claimed the lives of over 4 million people worldwide since it first appeared in December 2019. There are currently no drugs that can effectively arrest replication of the virus in people who have contracted the illness.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Montréal, Quebec, Canada, North America
Founded on
January 1, 2006
Exited on
October 30, 2009
Went public on
October 30, 2009
Stock symbol
SBFM
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noway Youcantaccess
Sign in for full access